コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tion combined with antibody staining for the HIV Gag protein.
2 a recombinant vaccinia virus expressing the HIV Gag protein.
3 ween cytosolic immature and endocytic mature HIV gag protein.
4 the C terminus of HIV p17 matrix within the HIV gag protein.
5 tanus toxoid precursor, EBV nuclear Ag 2, or HIV gag protein.
6 human primates (NHPs) when administered with HIV Gag protein.
7 th recombinant vaccinia virus expressing the HIV Gag protein.
8 PCs) of the mutational correlation matrix of HIV Gag proteins.
9 psid domain of human immunodeficiency virus (HIV) gag protein.
10 (IBS) from the human immunodeficiency virus (HIV) Gag protein.
13 an rNDV vector expressing a codon-optimized HIV Gag protein and demonstrated its ability to induce a
15 xic T lymphocyte (CTL) responses against the HIV Gag protein are associated with lowering viremia; ho
17 le trap assay, based on co-expression of the HIV Gag protein, confirmed that this post-translational
19 Our in vivo experiments revealed that higher HIV Gag protein expression positively correlates with an
20 vant was administered alone or together with HIV Gag protein (Gag), and the magnitude, quality, and p
23 contrast, the human immunodeficiency virus (HIV) Gag protein is incapable of assembly in parallel as
27 n also induce stronger responses against the HIV Gag protein relative to the Env protein after vaccin
28 lectively, our results show that conjugating HIV Gag protein to a TLR7/8 agonist is an effective way
31 raction of the human immunodeficiency virus (HIV) Gag protein with the plasma membrane of a cell is a